<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0650">
 <label>130</label>
 <element-citation publication-type="journal" id="rf0645">
  <person-group person-group-type="author">
   <name>
    <surname>Berger</surname>
    <given-names>J.R.</given-names>
   </name>
   <name>
    <surname>Brandstadter</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Bar-Or</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>COVID-19 and MS disease-modifying therapies</article-title>
  <source>Neurol Neuroimmunol Neuroinflamm.</source>
  <volume>7</volume>
  <issue>4</issue>
  <year>2020 May 15</year>
  <fpage>e761</fpage>
  <pub-id pub-id-type="pmid">32414755</pub-id>
 </element-citation>
</ref>
